Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visipaque 320. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101293855B reveals cost-effective recrystallization for high-purity contrast agents ensuring supply chain stability and significant manufacturing cost reduction for global buyers.
Advanced patent CN102079716A details a buffered dimerization and resin purification method for high-purity Iodixanol, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103058880A reveals a novel Iodixanol intermediate synthesis route. Achieve >90% crude purity and simplified purification for reliable pharmaceutical supply chains.